Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary P Sims

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|September 10, 2011
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivoElizabeth Ward, Nanette Mittereder, Ellen Kuta, et al.
Arthritis Research & Therapy|June 23, 2026
Targeting inflammatory and angiogenic responses by small-molecule kinase inhibitors in a 3D macrophage-containing spheroid model of rheumatoid arthritis synovial tissueEva M L Philippon, Lisanne J E van Rooijen, Aldo Jongejan, et al.
Journal of Proteome Research|May 19, 2021
Characterization of Citrullination Sites in Neutrophils and Mast Cells Activated by Ionomycin via Integration of Mass Spectrometry and Machine LearningRaghothama Chaerkady, Yebin Zhou, Jared A Delmar, et al.
The Journal of Infectious Diseases|January 21, 2012
Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infectionAllison L Miller, Gary P Sims, Yambasu A Brewah, et al.
Molecular Medicine (Cambridge, Mass.)|May 14, 2008
Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alphaBo Chen, Qin Zong, Ricardo Cibotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2020
Immune Complex-Driven Generation of Human Macrophages with Anti-Inflammatory and Growth-Promoting ActivityElizabeth Dalby, Stephen M Christensen, Jingya Wang, et al.
Lupus Science & Medicine|April 13, 2018
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusJeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, et al.
Plos One|March 18, 2020
LOX-1: A potential driver of cardiovascular risk in SLE patientsDivya Sagar, Ranjitha Gaddipati, Emily L Ongstad, et al.
Arthritis and Rheumatism|February 5, 2010
Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ cultureHans P Kiener, Gerald F M Watts, Yajun Cui, et al.
Plos One|February 24, 2015
S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivoBo Chen, Allison L Miller, Marlon Rebelatto, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|September 10, 2011
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivoElizabeth Ward, Nanette Mittereder, Ellen Kuta, et al.
Arthritis Research & Therapy|June 23, 2026
Targeting inflammatory and angiogenic responses by small-molecule kinase inhibitors in a 3D macrophage-containing spheroid model of rheumatoid arthritis synovial tissueEva M L Philippon, Lisanne J E van Rooijen, Aldo Jongejan, et al.
Journal of Proteome Research|May 19, 2021
Characterization of Citrullination Sites in Neutrophils and Mast Cells Activated by Ionomycin via Integration of Mass Spectrometry and Machine LearningRaghothama Chaerkady, Yebin Zhou, Jared A Delmar, et al.
The Journal of Infectious Diseases|January 21, 2012
Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infectionAllison L Miller, Gary P Sims, Yambasu A Brewah, et al.
Molecular Medicine (Cambridge, Mass.)|May 14, 2008
Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alphaBo Chen, Qin Zong, Ricardo Cibotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2020
Immune Complex-Driven Generation of Human Macrophages with Anti-Inflammatory and Growth-Promoting ActivityElizabeth Dalby, Stephen M Christensen, Jingya Wang, et al.
Lupus Science & Medicine|April 13, 2018
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusJeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, et al.
Plos One|March 18, 2020
LOX-1: A potential driver of cardiovascular risk in SLE patientsDivya Sagar, Ranjitha Gaddipati, Emily L Ongstad, et al.
Arthritis and Rheumatism|February 5, 2010
Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ cultureHans P Kiener, Gerald F M Watts, Yajun Cui, et al.
Plos One|February 24, 2015
S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivoBo Chen, Allison L Miller, Marlon Rebelatto, et al.
Pageof 4